{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:32Z","timestamp":1787003672805,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"BioNTech R&D (Austria) GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14753-y","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T10:46:55Z","timestamp":1754909215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discovery of potent endolysins against Pseudomonas aeruginosa and other gram-negative ESKAPE pathogens by an agar-based screening method"],"prefix":"10.1038","volume":"15","author":[{"given":"Vera","family":"Oberbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Mutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Schwebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Durica-Mitic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Visram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donaat","family":"Kestemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Badarau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"14753_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"LB Rice","year":"2008","unstructured":"Rice, L. B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 197, 1079\u20131081. https:\/\/doi.org\/10.1086\/533452 (2008).","journal-title":"J. Infect. Dis."},{"key":"14753_CR2","unstructured":"World Health Organization. WHO Bacterial Priority Pathogens List 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance (2024)."},{"key":"14753_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jcf.2019.08.006","volume":"19","author":"E Hatziagorou","year":"2020","unstructured":"Hatziagorou, E. et al. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis\u2013data from the European cystic fibrosis society patient registry. J. Cyst. Fibros. 19, 376\u2013383. https:\/\/doi.org\/10.1016\/j.jcf.2019.08.006 (2020).","journal-title":"J. Cyst. Fibros."},{"key":"14753_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.burns.2003.08.007","volume":"30","author":"EE Tredget","year":"2004","unstructured":"Tredget, E. E., Shankowsky, H. A., Rennie, R., Burrell, R. E. & Logsetty, S. Pseudomonas infections in the thermally injured patient. Burns 30, 3\u201326. https:\/\/doi.org\/10.1016\/j.burns.2003.08.007 (2004).","journal-title":"Burns"},{"key":"14753_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/idr.S50669","volume":"9","author":"S Ram\u00edrez-Estrada","year":"2016","unstructured":"Ram\u00edrez-Estrada, S., Borgatta, B. & Rello, J. Pseudomonas aeruginosa ventilator-associated pneumonia management. Infect. Drug Resist. 9, 7\u201318. https:\/\/doi.org\/10.2147\/idr.S50669 (2016).","journal-title":"Infect. Drug Resist."},{"key":"14753_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijid.2023.11.023","volume":"139","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. The global epidemiology of ventilator-associated pneumonia caused by multi-drug resistant Pseudomonas aeruginosa: A systematic review and meta-analysis. Int. J. Infect. Dis. 139, 78\u201385. https:\/\/doi.org\/10.1016\/j.ijid.2023.11.023 (2024).","journal-title":"Int. J. Infect. Dis."},{"key":"14753_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0 (2022).","journal-title":"Lancet"},{"key":"14753_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/J.MIB.2008.09.012","volume":"11","author":"VA Fischetti","year":"2008","unstructured":"Fischetti, V. A. Bacteriophage lysins as effective antibacterials. Curr. Opin. Microbiol. 11, 393\u2013393. https:\/\/doi.org\/10.1016\/J.MIB.2008.09.012 (2008).","journal-title":"Curr. Opin. Microbiol."},{"key":"14753_CR9","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.mib.2024.102433","volume":"78","author":"HM Sisson","year":"2024","unstructured":"Sisson, H. M., Jackson, S. A., Fagerlund, R. D., Warring, S. L. & Fineran, P. C. Gram-negative endolysins: overcoming the outer membrane obstacle. Curr. Opin. Microbiol. 78, 102433. https:\/\/doi.org\/10.1016\/j.mib.2024.102433 (2024).","journal-title":"Curr. Opin. Microbiol."},{"key":"14753_CR10","doi-asserted-by":"crossref","unstructured":"Dams, D. & Briers, Y. in Therapeutic Enzymes: Function and Clinical Implications (ed Nikolaos Labrou) 233\u2013253Springer Singapore, (2019).","DOI":"10.1007\/978-981-13-7709-9_11"},{"key":"14753_CR11","doi-asserted-by":"publisher","unstructured":"Briers, Y. et al. Engineered endolysin-based Artilysins to combat multidrug-resistant Gram-negative pathogens. mBio 5, e01379-01314 (2014). https:\/\/doi.org\/10.1128\/mBio.01379-14","DOI":"10.1128\/mBio.01379-14"},{"key":"14753_CR12","doi-asserted-by":"publisher","unstructured":"Heselpoth, R. D., Euler, C. W., Schuch, R. & Fischetti, V. A. Lysocins: bioengineered antimicrobials that deliver lysins across the outer membrane of Gram-Negative bacteria. Antimicrob. Agents Chemother. 63 https:\/\/doi.org\/10.1128\/aac.00342-19 (2019).","DOI":"10.1128\/aac.00342-19"},{"key":"14753_CR13","doi-asserted-by":"publisher","first-page":"12087","DOI":"10.1038\/s41598-020-68983-3","volume":"10","author":"A Zampara","year":"2020","unstructured":"Zampara, A. et al. Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria. Sci. Rep. 10, 12087. https:\/\/doi.org\/10.1038\/s41598-020-68983-3 (2020).","journal-title":"Sci. Rep."},{"key":"14753_CR14","doi-asserted-by":"publisher","first-page":"eaaz1136","DOI":"10.1126\/sciadv.aaz1136","volume":"6","author":"H Gerstmans","year":"2020","unstructured":"Gerstmans, H. et al. A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins. Sci. Adv. 6, eaaz1136. https:\/\/doi.org\/10.1126\/sciadv.aaz1136 (2020).","journal-title":"Sci. Adv."},{"key":"14753_CR15","doi-asserted-by":"publisher","unstructured":"Sui, B. et al. Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria. Appl Environ Microbiol, e0058123 (2023). https:\/\/doi.org\/10.1128\/aem.00581-23","DOI":"10.1128\/aem.00581-23"},{"key":"14753_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/v17020200","volume":"17","author":"M Kogawa","year":"2025","unstructured":"Kogawa, M. et al. Development of chimera AMP\u2013Endolysin with wider spectra against Gram-Negative bacteria using High-Throughput assay. Viruses 17, 200. https:\/\/doi.org\/10.3390\/v17020200 (2025).","journal-title":"Viruses"},{"key":"14753_CR17","doi-asserted-by":"publisher","unstructured":"Blasco, L. et al. In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens. Sci. Rep. 10, 7163 (2020). https:\/\/doi.org\/10.1038\/s41598-020-64145-7","DOI":"10.1038\/s41598-020-64145-7"},{"key":"14753_CR18","doi-asserted-by":"publisher","first-page":"7181","DOI":"10.1128\/aem.00732-10","volume":"76","author":"JE Schmitz","year":"2010","unstructured":"Schmitz, J. E., Schuch, R. & Fischetti, V. A. Identifying active phage lysins through functional viral metagenomics. Appl. Environ. Microbiol. 76, 7181\u20137187. https:\/\/doi.org\/10.1128\/aem.00732-10 (2010).","journal-title":"Appl. Environ. Microbiol."},{"key":"14753_CR19","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1128\/aac.04641-14","volume":"59","author":"R Lood","year":"2015","unstructured":"Lood, R. et al. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model. Antimicrob. Agents Chemother. 59, 1983\u20131991. https:\/\/doi.org\/10.1128\/aac.04641-14 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"14753_CR20","doi-asserted-by":"publisher","first-page":"17257","DOI":"10.1038\/srep17257","volume":"5","author":"H Yang","year":"2015","unstructured":"Yang, H. et al. A chimeolysin with extended-spectrum Streptococcal host range found by an induced lysis-based rapid screening method. Sci. Rep. 5, 17257. https:\/\/doi.org\/10.1038\/srep17257 (2015).","journal-title":"Sci. Rep."},{"key":"14753_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-1-60327-565-1_18","volume":"502","author":"R Schuch","year":"2009","unstructured":"Schuch, R., Fischetti, V. A. & Nelson, D. C. A genetic screen to identify bacteriophage lysins. Methods Mol. Biol. 502, 307\u2013319. https:\/\/doi.org\/10.1007\/978-1-60327-565-1_18 (2009).","journal-title":"Methods Mol. Biol."},{"key":"14753_CR22","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1365-2958.1995.tb02345.x","volume":"16","author":"MJ Loessner","year":"1995","unstructured":"Loessner, M. J., Wendlinger, G. & Scherer, S. Heterogeneous endolysins in Listeria monocytogenes bacteriophages: a new class of enzymes and evidence for conserved Holin genes within the siphoviral Lysis cassettes. Mol. Microbiol. 16, 1231\u20131241. https:\/\/doi.org\/10.1111\/j.1365-2958.1995.tb02345.x (1995).","journal-title":"Mol. Microbiol."},{"key":"14753_CR23","first-page":"A1","volume":"2022\/204280","author":"R Schuch","year":"2022","unstructured":"Schuch, R. Amurins lysins, and lysin-antimicrobial peptide (AMP) constructs active against gram-negative bacteria. WO Patent WO. 2022\/204280, A1 (2022).","journal-title":"WO Patent WO"},{"key":"14753_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1574-6968.2008.01089.x","volume":"281","author":"T Inoue","year":"2008","unstructured":"Inoue, T., Shingaki, R. & Fukui, K. Inhibition of swarming motility of Pseudomonas aeruginosa by branched-chain fatty acids. FEMS Microbiol. Lett. 281, 81\u201386. https:\/\/doi.org\/10.1111\/j.1574-6968.2008.01089.x (2008).","journal-title":"FEMS Microbiol. Lett."},{"key":"14753_CR25","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1128\/jvi.03277-12","volume":"87","author":"H Oliveira","year":"2013","unstructured":"Oliveira, H. et al. Molecular aspects and comparative genomics of bacteriophage endolysins. J. Virol. 87, 4558\u20134570. https:\/\/doi.org\/10.1128\/jvi.03277-12 (2013).","journal-title":"J. Virol."},{"key":"14753_CR26","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Ruiz, I., Coutinho, F. H. & Rodriguez-Valera, F. Thousands of novel endolysins discovered in uncultured phage genomes. Front. Microbiol. 9 https:\/\/doi.org\/10.3389\/fmicb.2018.01033 (2018).","DOI":"10.3389\/fmicb.2018.01033"},{"key":"14753_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0167-4838(92)90073-M","volume":"1159","author":"J Caldentey","year":"1992","unstructured":"Caldentey, J. & Bamford, D. H. The lytic enzyme of the Pseudomonas phage \u03c66. Purification and biochemical characterization. Biochim. Et Biophys. Acta (BBA) - Protein Struct. Mol. Enzymol. 1159, 44\u201350. https:\/\/doi.org\/10.1016\/0167-4838(92)90073-M (1992).","journal-title":"Biochim. Et Biophys. Acta (BBA) - Protein Struct. Mol. Enzymol."},{"key":"14753_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1128\/jvi.58.1.142-151.1986","volume":"58","author":"T McGraw","year":"1986","unstructured":"McGraw, T., Mindich, L. & Frangione, B. Nucleotide sequence of the small double-stranded RNA segment of bacteriophage phi 6: novel mechanism of natural translational control. J. Virol. 58, 142\u2013151. https:\/\/doi.org\/10.1128\/jvi.58.1.142-151.1986 (1986).","journal-title":"J. Virol."},{"key":"14753_CR29","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1110\/ps.041250005","volume":"14","author":"J Pei","year":"2005","unstructured":"Pei, J. & Grishin, N. V. The P5 protein from bacteriophage phi-6 is a distant homolog of lytic transglycosylases. Protein Sci. 14, 1370\u20131374. https:\/\/doi.org\/10.1110\/ps.041250005 (2005).","journal-title":"Protein Sci."},{"key":"14753_CR30","doi-asserted-by":"publisher","first-page":"e1003102","DOI":"10.1371\/journal.pgen.1003102","volume":"8","author":"M Dessau","year":"2012","unstructured":"Dessau, M., Goldhill, D., McBride, R. L., Turner, P. E. & Modis, Y. Selective pressure causes an RNA virus to trade reproductive fitness for increased structural and thermal stability of a viral enzyme. PLoS Genet. 8, e1003102. https:\/\/doi.org\/10.1371\/journal.pgen.1003102 (2012).","journal-title":"PLoS Genet."},{"key":"14753_CR31","doi-asserted-by":"publisher","first-page":"14501","DOI":"10.1038\/s41598-017-14797-9","volume":"7","author":"B Maciejewska","year":"2017","unstructured":"Maciejewska, B. et al. Modular endolysin of Burkholderia AP3 phage has the largest lysozyme-like catalytic subunit discovered to date and no catalytic aspartate residue. Sci. Rep. 7, 14501. https:\/\/doi.org\/10.1038\/s41598-017-14797-9 (2017).","journal-title":"Sci. Rep."},{"key":"14753_CR32","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1128\/aem.00446-16","volume":"82","author":"L Rodr\u00edguez-Rubio","year":"2016","unstructured":"Rodr\u00edguez-Rubio, L. et al. DUF3380 domain from a Salmonella phage endolysin shows potent N-Acetylmuramidase activity. Appl. Environ. Microbiol. 82, 4975\u20134981. https:\/\/doi.org\/10.1128\/aem.00446-16 (2016).","journal-title":"Appl. Environ. Microbiol."},{"key":"14753_CR33","doi-asserted-by":"publisher","unstructured":"Farris, M. H., Ford, K. A. & Doyle, R. C. Qualitative and quantitative assays for detection and characterization of protein antimicrobials. JoVE e53819. https:\/\/doi.org\/10.3791\/53819 (2016).","DOI":"10.3791\/53819"},{"key":"14753_CR34","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrmicro2405","volume":"8","author":"DB Kearns","year":"2010","unstructured":"Kearns, D. B. A field guide to bacterial swarming motility. Nat. Rev. Microbiol. 8, 634\u2013644. https:\/\/doi.org\/10.1038\/nrmicro2405 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"14753_CR35","doi-asserted-by":"publisher","unstructured":"Jeong, T. H., Hong, H. W., Kim, M. S., Song, M. & Myung, H. Characterization of three different endolysins effective against Gram-Negative bacteria. Viruses 15 https:\/\/doi.org\/10.3390\/v15030679 (2023).","DOI":"10.3390\/v15030679"},{"key":"14753_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae027","author":"K Sauve","year":"2024","unstructured":"Sauve, K. et al. The engineered lysin, CF-370, is active against Antibiotic-Resistant Gram-Negative pathogens in vitro and synergizes with meropenem in experimental Pseudomonas aeruginosa pneumonia. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiae027 (2024).","journal-title":"J. Infect. Dis."},{"key":"14753_CR37","doi-asserted-by":"publisher","first-page":"e14513","DOI":"10.1111\/1751-7915.14513","volume":"17","author":"R V\u00e1zquez","year":"2024","unstructured":"V\u00e1zquez, R. et al. You get what you test for: the killing effect of phage lysins is highly dependent on buffer tonicity and ionic strength. Microb. Biotechnol. 17, e14513. https:\/\/doi.org\/10.1111\/1751-7915.14513 (2024).","journal-title":"Microb. Biotechnol."},{"key":"14753_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1128\/aac.26.1.48","volume":"26","author":"RE Hancock","year":"1984","unstructured":"Hancock, R. E. & Wong, P. G. Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane. Antimicrob. Agents Chemother. 26, 48\u201352. https:\/\/doi.org\/10.1128\/aac.26.1.48 (1984).","journal-title":"Antimicrob. Agents Chemother."},{"key":"14753_CR39","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2217\/fmb.12.97","volume":"7","author":"M Schmelcher","year":"2012","unstructured":"Schmelcher, M., Donovan, D. M. & Loessner, M. J. Bacteriophage endolysins as novel antimicrobials. Future Microbiol. 7, 1147\u20131171. https:\/\/doi.org\/10.2217\/fmb.12.97 (2012).","journal-title":"Future Microbiol."},{"key":"14753_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1128\/br.36.4.407-477.1972","volume":"36","author":"KH Schleifer","year":"1972","unstructured":"Schleifer, K. H. & Kandler, O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36, 407\u2013477. https:\/\/doi.org\/10.1128\/br.36.4.407-477.1972 (1972).","journal-title":"Bacteriol. Rev."},{"key":"14753_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3184\/003685016x14627913637705","volume":"99","author":"J Ajuebor","year":"2016","unstructured":"Ajuebor, J. et al. Bacteriophage endolysins and their applications. Sci. Prog. 99, 183\u2013199. https:\/\/doi.org\/10.3184\/003685016x14627913637705 (2016).","journal-title":"Sci. Prog"},{"key":"14753_CR42","doi-asserted-by":"publisher","unstructured":"Murray, E., Draper, L. A., Ross, R. P. & Hill, C. The advantages and challenges of using endolysins in a clinical setting. Viruses 13 https:\/\/doi.org\/10.3390\/v13040680 (2021).","DOI":"10.3390\/v13040680"},{"key":"14753_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.plasmid.2005.07.001","volume":"55","author":"JE Cronan","year":"2006","unstructured":"Cronan, J. E. A family of arabinose-inducible Escherichia coli expression vectors having pBR322 copy control. Plasmid 55, 152\u2013157. https:\/\/doi.org\/10.1016\/j.plasmid.2005.07.001 (2006).","journal-title":"Plasmid"},{"key":"14753_CR44","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/s0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403\u2013410. https:\/\/doi.org\/10.1016\/s0022-2836(05)80360-2 (1990).","journal-title":"J. Mol. Biol."},{"key":"14753_CR45","doi-asserted-by":"publisher","first-page":"D412","DOI":"10.1093\/nar\/gkaa913","volume":"49","author":"J Mistry","year":"2020","unstructured":"Mistry, J. et al. Pfam: the protein families database in 2021. Nucleic Acids Res. 49, D412\u2013D419. https:\/\/doi.org\/10.1093\/nar\/gkaa913 (2020).","journal-title":"Nucleic Acids Res."},{"key":"14753_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1574-6968.2012.02585.x","volume":"332","author":"V Szij\u00e1rt\u00f3","year":"2012","unstructured":"Szij\u00e1rt\u00f3, V. et al. The rapidly emerging ESBL-producing Escherichia coli O25-ST131 clone carries LPS core synthesis genes of the K-12 type. FEMS Microbiol. Lett. 332, 131\u2013136. https:\/\/doi.org\/10.1111\/j.1574-6968.2012.02585.x (2012).","journal-title":"FEMS Microbiol. Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14753-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14753-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14753-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T23:02:34Z","timestamp":1755298954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14753-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14753"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14753-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conflicts of interest have been declared by the following authors: V.O., M.M., T.S., S.D., Z.V., D.K., A.B. and L.C. are employees at BioNTech R&D (Austria) GmbH.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29351"}}